Werewolf Therapeutics, Inc. financial data

Symbol
HOWL on Nasdaq
Location
Watertown, MA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 597% % -29%
Debt-to-equity 101% % 91%
Return On Equity -144% % -145%
Return On Assets -72% % -86%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48,540,200 shares 8.9%
Common Stock, Shares, Outstanding 47,273,685 shares 8.1%
Entity Public Float $69,689,962 USD 3.5%
Common Stock, Value, Issued $5,000 USD 25%
Weighted Average Number of Shares Outstanding, Basic 45,804,042 shares 4.8%
Weighted Average Number of Shares Outstanding, Diluted 45,804,042 shares 4.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $53,624,000 USD 6.5%
General and Administrative Expense $17,983,000 USD -6.5%
Operating Income (Loss) $71,607,000 USD -8.2%
Nonoperating Income (Expense) $1,234,000 USD -130%
Net Income (Loss) Attributable to Parent $72,841,000 USD -17%
Earnings Per Share, Basic -1 USD/shares -7.3%
Earnings Per Share, Diluted -1 USD/shares -3.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $65,711,000 USD -47%
Assets, Current $68,173,000 USD -46%
Property, Plant and Equipment, Net $5,088,000 USD -25%
Operating Lease, Right-of-Use Asset $5,422,000 USD -12%
Other Assets, Noncurrent $46,000 USD 9.5%
Assets $79,627,000 USD -43%
Accounts Payable, Current $1,078,000 USD -13%
Employee-related Liabilities, Current $2,885,000 USD 3%
Accrued Liabilities, Current $9,021,000 USD -8.9%
Contract with Customer, Liability, Current $0 USD -100%
Liabilities, Current $17,603,000 USD 41%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Operating Lease, Liability, Noncurrent $8,140,000 USD -17%
Liabilities $50,013,000 USD -1.3%
Retained Earnings (Accumulated Deficit) $467,029,000 USD -18%
Stockholders' Equity Attributable to Parent $29,614,000 USD -67%
Liabilities and Equity $79,627,000 USD -43%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $18,948,000 USD -24%
Net Cash Provided by (Used in) Financing Activities $0 USD -100%
Net Cash Provided by (Used in) Investing Activities $0 USD
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 47,273,685 shares 8.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $18,948,000 USD -491%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $66,609,000 USD -46%
Interest Paid, Excluding Capitalized Interest, Operating Activities $773,000 USD -15%
Deferred Tax Assets, Valuation Allowance $67,756,000 USD 44%
Deferred Tax Assets, Gross $70,328,000 USD 40%
Operating Lease, Liability $10,992,000 USD -13%
Depreciation $426,000 USD -8.2%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Lessee, Operating Lease, Liability, to be Paid $13,469,000 USD -16%
Property, Plant and Equipment, Gross $11,306,000 USD 1.6%
Operating Lease, Liability, Current $1,504,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid, Year Two $2,403,000 USD 2.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $2,337,000 USD -6.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $2,477,000 USD -27%
Lessee, Operating Lease, Liability, to be Paid, Year Three $2,471,000 USD 2.8%
Deferred Tax Assets, Operating Loss Carryforwards $32,781,000 USD 37%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $2,542,000 USD 2.9%
Additional Paid in Capital $496,638,000 USD 2.7%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $2,572,000 USD -20%
Share-based Payment Arrangement, Expense $6,940,000 USD -21%
Interest Expense $1,003,000 USD 483%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%